Other
Operating And Finance Lease, Liability, Current
Moderna Operating And Finance Lease, Liability, Current increased by 19.0% to $50M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 16.3%, from $43M to $50M. Over 5 years (FY 2020 to FY 2025), Operating And Finance Lease, Liability, Current shows an upward trend with a 7.0% CAGR.
Analysis
StatementBalance Sheet Statement
SectionOther
First reportedQ4 2020
Last reportedQ1 2026May 1, 2026
Metric ID:
other_operating_and_finance_lease_liability_current_2237a5Historical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $170M | $240M | $211M | $206M | $159M | $260M | $196M | $181M | $221M | $183M | $25M | $25M | $25M | $51M | $37M | $43M | $43M | $48M | $42M | $50M |
| QoQ Change | — | +41.2% | -12.1% | -2.4% | -22.8% | +63.5% | -24.6% | -7.7% | +22.1% | -17.2% | -86.3% | +0.0% | +0.0% | +104.0% | -27.5% | +16.2% | +0.0% | +11.6% | -12.5% | +19.0% |
| YoY Change | — | — | — | — | -6.5% | +8.3% | -7.1% | -12.1% | +39.0% | -29.6% | -87.2% | -86.2% | -88.7% | -72.1% | +48.0% | +72.0% | +72.0% | -5.9% | +13.5% | +16.3% |
Range$25M – $260M
CAGR-22.7%
Avg YoY Growth-7.9%
Median YoY Growth-6.2%
Frequently Asked Questions
- What is Moderna's operating and finance lease, liability, current?
- Moderna (MRNA) reported operating and finance lease, liability, current of $50M in Q1 2026.
- How has Moderna's operating and finance lease, liability, current changed year-over-year?
- Moderna's operating and finance lease, liability, current increased by 16.3% year-over-year, from $43M to $50M.
- What is the long-term trend for Moderna's operating and finance lease, liability, current?
- Over 5 years (2020 to 2025), Moderna's operating and finance lease, liability, current has grown at a 7.0% compound annual growth rate (CAGR), from $30M to $42M.